Skip to content
  • Tuesday, 25 August 2026
  • 2:44 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 18, 2026 0

AustinPx, a Contract Development and Manufacturing Organization (CDMO) based in Texas, has forged an exclusive agreement with Thermo Fisher Scientific’s…

Read More
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 10, 2026 0

AustinPx, a Texas-based Contract Development and Manufacturing Organization (CDMO) specializing in bioavailability enhancement, has forged an exclusive agreement with Thermo…

Read More
American Diabetes Association Conference: Groundbreaking GLP-1 Discoveries Eclipsed by Scientific Freedom ProtestAmphibian Recovery Mystery Solved: Early Immune Development Crucial for Survival Against Deadly FungusScience News: A Century of Empowering Public Understanding of ScienceOptical Control of Topological Ferromagnetism Enables Direct Writing of Electronic Circuits on Quantum Materials
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ